XP21279 with Lodosyn

· XenoPort, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XP21279 with Lodosyn, covering 2021-05-05 to 2021-05-05. Get the full timeline:

Most recent: Clinical Trial Update: An Exploratory Study of XP21279 (With Lodosyn®) and Sinemet® in Parkinson's Disease Subjects [Phase 1, Phase 2]